Principal Financial Group Inc Sesen Bio, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.38 - $0.89 $22,514 - $52,731	-59,249 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.58 - $0.86 $762 - $1,130	1,314 Added 2.27%	59,249 $35,000
Q4 2021 Feb 09, 2022	SELL	$0.73 - $1.28 $337,560 - $591,886	-462,411 Reduced 88.87%	57,935 $47,000
Q3 2021 Nov 09, 2021	BUY	$0.77 - $4.91 $4,355 - $27,770	5,656 Added 1.1%	520,346 $413,000
Q2 2021 Aug 10, 2021	BUY	$2.18 - $4.66 $1.12 Million - $2.4 Million	514,690 New	514,690 $2.38 Million

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.